Tandospirone, a 5-HT1A agonist, ameliorates movement disorder via non-dopaminergic systems in rats with unilateral 6-hydroxydopamine-generated lesions
Keywords: GABA, γ-aminobutyric acid; 5-HT1A, serotonin 1A; l-DOPA, 3,4-dihydroxyphenylalanaine; NMDA, N-methyl-d-asparate; 6-OHDA, 6-hydroxydopamine; 8-OHDPAT, 8-hydroxy-2-(di-n-propylamino) tetralin; PD, Parkinson's diseaseParkinson disease; 5-HT1A receptor agonis